ZIVO Bioscience, Inc. (ZIVO)

Last Closing Price: 2.75 (2023-06-02)

Company Description

Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.02M
Net Income (Most Recent Fiscal Year) $-8.74M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -1249.74%
Return on Assets (Trailing 12 Months) -265.61%
Current Ratio (Most Recent Fiscal Quarter) 0.33
Quick Ratio (Most Recent Fiscal Quarter) 0.33
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.00
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-0.99
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 9.42M
Free Float 8.16M
Market Capitalization $25.90M
Average Volume (Last 20 Days) 4732.55
Beta (Past 60 Months) 0.18
Percentage Held By Insiders (Latest Annual Proxy Report) 13.40%
Percentage Held By Institutions (Latest 13F Reports) 5.05%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%